Literature DB >> 21749583

Risk factors for high-risk human papillomavirus infection in unscreened Malian women.

J Kathleen Tracy1, Cheick B Traore, Kamate Bakarou, Rokiatou Dembelé, Rokiatou C Coulibaly, Samba O Sow.   

Abstract

OBJECTIVE: To investigate the epidemiology of human papillomavirus (HPV) infection in Malian women, for whom cervical cancer is the most common cancer and the second most common cause of cancer-related mortality.
METHODS: Pilot study of 202 women aged 15-65 to determine the prevalence rate of high-risk HPV infection among unscreened Malian women. Information on risk factors was collected through a standardized, structured interview and clinical examination. High-risk (HR) HPV DNA was detected using signal amplification methods (hybrid capture II).
RESULTS: High-risk HPV DNA was detected in 12% of unscreened women, while visual inspection after application of acetic acid and Lugol's iodine (VIA/VILI) identified suspicious abnormalities in 2.5% of unscreened women. Histopathological evaluation of VIA/VILI-positive biopsies revealed no evidence of cervical intraepithelial neoplasia or cervical cancer. The majority of infections occurred among women in the 15-24 year old range. Compared to women who were married or widowed, single women were 3.5 times more likely to be infected with HR HPV.
CONCLUSIONS: The prevalence of infection with cancer causing types of HPV in this study was 12%. These prevalence estimates are consistent with what has been reported previously for other West African countries.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749583      PMCID: PMC3222725          DOI: 10.1111/j.1365-3156.2011.02843.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  11 in total

1.  Effects of mutual health organizations on use of priority health-care services in urban and rural Mali: a case-control study.

Authors:  Lynne Miller Franco; François Pathé Diop; Clara R Burgert; Allison Gamble Kelley; Marty Makinen; Cheick Hamed Tidiane Simpara
Journal:  Bull World Health Organ       Date:  2008-11       Impact factor: 9.408

2.  From India to the world--a better way to prevent cervical cancer.

Authors:  Mark Schiffman; Sholom Wacholder
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

3.  A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

Authors:  You-Lin Qiao; John W Sellors; Paul S Eder; Yan-Ping Bao; Jeanette M Lim; Fang-Hui Zhao; Bernhard Weigl; Wen-Hua Zhang; Roger B Peck; Ling Li; Feng Chen; Qing-Jing Pan; Attila T Lorincz
Journal:  Lancet Oncol       Date:  2008-09-19       Impact factor: 41.316

4.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

5.  Risk factors of invasive cervical cancer in Mali.

Authors:  Siné Bayo; F Xavier Bosch; Silvia de Sanjosé; Nubia Muñoz; Alba Lucia Combita; Pierre Coursaget; Mireia Diaz; Amardou Dolo; Adriaan J C van den Brule; Chris J M Meijer
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

Review 6.  Effective screening programmes for cervical cancer in low- and middle-income developing countries.

Authors:  R Sankaranarayanan; A M Budukh; R Rajkumar
Journal:  Bull World Health Organ       Date:  2001-11-01       Impact factor: 9.408

7.  Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.

Authors:  P E Gravitt; J V Lacey; L A Brinton; W A Barnes; J R Kornegay; M D Greenberg; S M Greene; O C Hadjimichael; L McGowan; R Mortel; P E Schwartz; R Zaino; A Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-02       Impact factor: 4.254

8.  Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda.

Authors:  Mahboobeh Safaeian; Mohammed Kiddugavu; Patti E Gravitt; Joseph Ssekasanvu; Dan Murokora; Marc Sklar; David Serwadda; Maria J Wawer; Keerti V Shah; Ron Gray
Journal:  Sex Transm Dis       Date:  2007-07       Impact factor: 2.830

9.  Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa.

Authors:  Rengaswamy Sankaranarayanan; Parthasarathy Basu; Ramani S Wesley; Cédric Mahe; Namory Keita; Charles C Gombe Mbalawa; Rameshwar Sharma; Amadou Dolo; Surendra S Shastri; Marius Nacoulma; Madi Nayama; Thara Somanathan; Eric Lucas; Richard Muwonge; Lucien Frappart; D Maxwell Parkin
Journal:  Int J Cancer       Date:  2004-07-20       Impact factor: 7.396

10.  HPV screening for cervical cancer in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Surendra S Shastri; Kasturi Jayant; Richard Muwonge; Atul M Budukh; Sanjay Hingmire; Sylla G Malvi; Ranjit Thorat; Ashok Kothari; Roshan Chinoy; Rohini Kelkar; Shubhada Kane; Sangeetha Desai; Vijay R Keskar; Raghevendra Rajeshwarkar; Nandkumar Panse; Ketayun A Dinshaw
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

View more
  7 in total

Review 1.  The burden of human papillomavirus infections and related diseases in sub-saharan Africa.

Authors:  Hugo De Vuyst; Laia Alemany; Charles Lacey; Carla J Chibwesha; Vikrant Sahasrabuddhe; Cecily Banura; Lynette Denny; Groesbeck P Parham
Journal:  Vaccine       Date:  2013-12-29       Impact factor: 3.641

2.  A cross-sectional study to assess HPV knowledge and HPV vaccine acceptability in Mali.

Authors:  Danielle N Poole; J Kathleen Tracy; Lauren Levitz; Mali Rochas; Kotou Sangare; Shahla Yekta; Karamoko Tounkara; Ben Aboubacar; Ousmane Koita; Mark Lurie; Anne S De Groot
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

3.  Risk factors for human papillomavirus infection prevalent among Uyghur women from Xinjiang, China.

Authors:  Guzhalinuer Abulizi; Hua Li; Patiman Mijiti; Tangnuer Abulimiti; Jing Cai; Jie Gao; Dandan Meng; Reyihanguli Abula; Tunishahan Abudereyimu; Anarguli Aizezi; You Lin Qiao
Journal:  Oncotarget       Date:  2017-06-30

4.  Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.

Authors:  Ibrahima Téguété; Amadou Dolo; Kotou Sangare; Abdoulaye Sissoko; Mali Rochas; Sarah Beseme; Karamoko Tounkara; Shahla Yekta; Anne S De Groot; Ousmane A Koita
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

5.  Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.

Authors:  Anne S De Groot; Karamoko Tounkara; Mali Rochas; Sarah Beseme; Shahla Yekta; Fanta Siby Diallo; J Kathleen Tracy; Ibrahima Teguete; Ousmane A Koita
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

6.  Human papillomavirus genotype distribution and factors associated among female sex workers in West Africa.

Authors:  Fatoumata Korika Tounkara; Ibrahima Téguété; Fernand A Guédou; Ella Goma-Matsétsé; Amadou Koné; Luc Béhanzin; Sidy Traoré; Marlène Aza-Gnandji; Bintou Keita; Julie Guenoun; François Coutlée; Michel Alary
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

7.  Differences in patterns of high-risk human papillomavirus infection between urban and rural low-resource settings: cross-sectional findings from Mali.

Authors:  Nicholas H Schluterman; Samba O Sow; Cheick B Traore; Kamate Bakarou; Rokiatou Dembelé; Founé Sacko; Patti E Gravitt; J Kathleen Tracy
Journal:  BMC Womens Health       Date:  2013-02-06       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.